Cytek Biosciences, Inc. (CTKB)
4.735
+0.12
(+2.49%)
USD |
NASDAQ |
Sep 09, 16:00
4.735
0.00 (0.00%)
After-Hours: 16:02
Cytek Biosciences Enterprise Value : 373.70M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 373.70M |
| September 04, 2026 | 384.10M |
| September 03, 2026 | 384.10M |
| September 02, 2026 | 382.80M |
| September 01, 2026 | 373.70M |
| August 31, 2026 | 394.49M |
| August 28, 2026 | 381.50M |
| August 27, 2026 | 373.70M |
| August 26, 2026 | 367.20M |
| August 25, 2026 | 368.50M |
| August 24, 2026 | 350.30M |
| August 21, 2026 | 398.39M |
| August 20, 2026 | 378.90M |
| August 19, 2026 | 384.10M |
| August 18, 2026 | 380.20M |
| August 17, 2026 | 389.30M |
| August 14, 2026 | 382.80M |
| August 13, 2026 | 408.79M |
| August 12, 2026 | 394.49M |
| August 11, 2026 | 389.30M |
| August 10, 2026 | 378.90M |
| August 07, 2026 | 319.10M |
| August 06, 2026 | 313.91M |
| August 05, 2026 | 316.51M |
| August 04, 2026 | 329.50M |
| Date | Value |
|---|---|
| August 03, 2026 | 333.40M |
| July 31, 2026 | 321.70M |
| July 30, 2026 | 333.40M |
| July 29, 2026 | 342.50M |
| July 28, 2026 | 352.90M |
| July 27, 2026 | 346.40M |
| July 24, 2026 | 352.90M |
| July 23, 2026 | 365.90M |
| July 22, 2026 | 363.30M |
| July 21, 2026 | 367.20M |
| July 20, 2026 | 368.50M |
| July 17, 2026 | 373.70M |
| July 16, 2026 | 376.30M |
| July 15, 2026 | 377.60M |
| July 14, 2026 | 373.70M |
| July 13, 2026 | 359.40M |
| July 10, 2026 | 373.70M |
| July 09, 2026 | 369.80M |
| July 08, 2026 | 343.80M |
| July 07, 2026 | 365.90M |
| July 06, 2026 | 373.70M |
| July 02, 2026 | 369.80M |
| July 01, 2026 | 368.50M |
| June 30, 2026 | 349.00M |
| June 29, 2026 | 334.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 43.60B |
| Bio-Rad Laboratories, Inc. | 9.914B |
| Bruker Corp. | 10.55B |
| Danaher Corp. | 167.78B |
| Harvard Bioscience, Inc. | 73.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.16M |
| Revenue (Quarterly) | 48.14M |
| Total Expenses (Quarterly) | 60.30M |
| EPS Diluted (Quarterly) | -0.0939 |
| Gross Profit Margin (Quarterly) | 58.87% |
| Profit Margin (Quarterly) | -25.26% |
| Earnings Yield | -13.25% |
| Normalized Earnings Yield | -13.07 |